USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: DYNAMIC CLINICAL SYSTEMS, INC.
Address: DYNAMIC CLINICAL SYSTEMS, INC.
BOX 5218
HANOVER, NH 03755-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,147,923.00 4
SBIR Phase II $1,198,447.00 1

Award List:

PLATFORM INDEPENDENT HUB FOR PATIENT REPORTED OUTCOMES IN ONCOLOGY (TOPIC 212)

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: John Weiss
Award Amount: $98,412.00

TITLE: PLATFORM INDEPENDENT HUB FOR PATIENT REPORTED OUTCOMES (PRO) IN ONCOLOGY.

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Weiss John
Award Amount: $750,000.00

SBIR TOPIC 246- INTEGRATING PATIENT-REPORTED OUTCOMES IN HOSPICE AND PALLIATIVE C

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Syed Abidi
Award Amount: $149,999.00
Abstract:
The long-term objective is to develop a highly secure, patient-friendly system for patients living with advanced cancer and their family caregivers to enable at-home symptom management and surveillance; to provide just-in-time, tailored, self-care educatio n; to measure patient-reported quality of… More

Not Available

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: John Weiss
Award Amount: $1,198,447.00
Abstract:
The long-term objective is to improve the care and quality of life for patients living with advanced cancer and  their family caregivers by implementing a highly secure, user-friendly system to:  - Maintain interactive symptom surveillance and medication adherence  - Measure… More

Research Platform Integrating Patient Reported and Clinical Outcomes Data Sources

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: John C. Weiss – 603-397-3637
Award Amount: $149,512.00
Abstract:
DESCRIPTION (provided by applicant): While large, prospective, blinded trials are the gold standard in clinical research, they require significant commitments of resources and time. Further, since these trials seek the answer to rather specific questions,the applicability and scalability of data… More